Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1672414

registered interest
date	22/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes and Obesity: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether her Department is taking steps to prevent second generation GLP-1 weight management medications being available for purchase online without prescription.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	3293
answer	answer is ministerial correction date of answer 28/11/2023 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) enforces the Human Medicines Regulations 2012 on behalf of the Secretary of State for Health and Social Care. Buying any medicinal product, including second generation glucagon-like peptide 1 weight management medications, from illegally trading online suppliers significantly increases the risk of getting a product which is either falsified or not licensed for use in the United Kingdom. The MHRA continues to work with social media and online sales platforms to build strong partnerships to identify and quickly remove illegal medicines from sale and to identify those unlawfully trading in medicines. We work with partners to remove web content where we can, and to block harmful URLs and domain names.</p><p>The MHRA works to prevent false customer feedback from promoting illegal online suppliers and has arrangements in place with major search engine providers to delist offending domain names. The MHRA also works with payment providers to disrupt the processing of payments via illegal sites. The MHRA will take appropriate enforcement action, including, where necessary, prosecuting those who put public health at risk.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 28/11/2023 13:00:15 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4488 label Biography information for Martyn Day

1672416

registered interest
date	22/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes and Obesity: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of the powers of the Medicines and Healthcare products Regulatory Agency to prevent the illegal online (a) marketing and (b) sale of (i) second generation GLP-1 weight management and (ii) other potentially hazardous medications.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	3295
answer	answer is ministerial correction date of answer 28/11/2023 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has the same powers available to other regulatory organisations and law enforcement agencies when addressing offending online. MHRA takes proportionate action, on a case-by-case basis, to enforce the Human Medicines Regulations 2012 in respect of the illegal sale and supply of second generation glucagon-like peptide 1 weight management medications and other potentially hazardous medications. In cases of serious non-compliance, the agency has the power to undertake formal criminal investigations and, where appropriate and evidentially supported, prosecution through the Crown Prosecution Service.</p><p>As this is primarily an online threat, MHRA works closely with social media providers, search engines and the broader internet industry to prevent and disrupt illegal sales and to identify and bring those responsible into compliance with the regulations.</p><p>Through its #Fakemeds campaign, MHRA uses social media and other channels to share safety advice and guidance with the public. The aim is to help patients protect their health by offering quick and easy tools and resources to help them avoid fake medical products when shopping online. With practical tips on how to recognise illegally trading websites and case studies of commonly falsified medicines, it also aims to educate the public on the dangers of buying unlicensed or fake medicines and empower them to make the right choices for their health.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 28/11/2023 12:27:40 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4488 label Biography information for Martyn Day

1672417

registered interest
date	22/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes and Obesity: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many prosecutions have been brought against sellers of (a) second generation GLP-1 weight management medications and (b) other potentially hazardous medications on the internet over the last 12 months.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	3296
answer	answer is ministerial correction date of answer 28/11/2023 answer text <p>To date, no prosecutions have been brought against those involved in the illegal sale of glucagon-like peptide 1 medicines although the Medicines and Healthcare products Regulatory Agency (MHRA) and Humberside Police were involved in executive action as recently as 23 November 2023 following an MHRA investigation into the alleged illegal supply of these products. During the last 12 months, MHRA has completed nine investigations involving the online sale of hazardous medicines. These investigations are at different stages within the criminal justice system.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 28/11/2023 12:26:11 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4488 label Biography information for Martyn Day